Synaptic Attack by ADDLs: A Mechanism for Memory Loss

About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2006 - March 31, 2009
Grant ID
A2006092
Goals
These experiments will examine how a class of molecules, ADDLs, detrimentally affect the structure of neurons.
Summary
Memory formation begins at synapses, and it appears likely that destruction of memory formation is due to synapse failure. Our proposal investigates the molecular cause of this failure. It focuses on a new neurotoxin, called ADDLs, that was discovered and characterized by our group over the past several years. We previously showed that ADDLs accumulate in AD brains, so it is important to know how they act. Our most recent work established that ADDLs attack synapses, a fact that gives very strong support to the idea that AD is a synapse failure. We now want to discover what type of structural and molecular damage ADDLs cause to synapses after they bind. Our preliminary evidence strongly indicates that ADDLs rapidly change the geometry of synapses into a shape often seen in mental retardation. Our evidence also indicates that the neurotransmitter receptor molecules required for information storage are removed from synapses. We plan to verify and extend these preliminary results by new experiments using state-of-the-art experimental models to study synapse biology and the impact of ADDLs. Our experiments in the long run will determine how the ADDLs attack on synapses could result in the catastrophic memory failure suffered in early Alzheimer’s disease.
Grants
Related Grants
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
Alzheimer's Disease Research
Decoding the Role of an Alzheimer's Causal Gene in Distinct Brain Cell Types
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Willem Annaert, PhD
Current Organization
Flemish Institute for Biotechnology
Alzheimer's Disease Research
Staging Alzheimer's Disease Using Blood Samples
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Gemma Salvadó, PhD
Current Organization
Lund University